Journal of the American Chemical Society
Communication
a
versatility of the product classes obtainable, we expect this
method to be of significant value in the areas of both natural
product and medicinal agent synthesis.
Table 3. DKR-ATH Substrate Scope
In summary, we have designed a new asymmetric transfer
hydrogenation catalyst that has led to the successful develop-
ment of the first dynamic kinetic resolution of β-aryl α-keto
esters. Under the reaction conditions, spontaneous lactoniza-
tion of the α-hydroxyl group onto the pendant ester occurs to
provide trisubstituted γ-butyrolactones with complete diaster-
eocontrol. With respect to the rubric of green chemistry, it is
instructive to inventory the three steps that lead to the lactones
2: (i) the Knoevenagel condensation is amine-catalyzed and
generates water as the byproduct; (ii) the glyoxylate Stetter
addition is carbene-catalyzed and is 100% atom economical,
generating no stoichiometric byproducts; (iii) the DKR-ATH
reaction uses a chiral ruthenium catalyst and formic acid as the
reductant and generates only CO2 and CH3OH as byproducts.
Further studies to understand the origin of selectivity, extend
this method to other β-stereogenic α-keto esters, and identify
other green, dynamic transformations with α-keto esters are
ongoing in our laboratory.
ASSOCIATED CONTENT
■
S
* Supporting Information
Experimental procedures and spectral, HPLC, and crystallo-
graphic (CIF) data. This material is available free of charge via
AUTHOR INFORMATION
■
a
Conditions: as described for Table 2.
Corresponding Author
Scheme 1. Catalyst Efficiency and Scalability
Notes
The authors declare no competing financial interest.
ACKNOWLEDGMENTS
■
The project described was supported by Award No. R01
GM084927 from the National Institute of General Medical
Sciences, Novartis, and Amgen. K.M.S. acknowledges an NIH
NRSA Fellowship to Promote Diversity in Health-Related
Research.
bond constructions. Of particular importance, alkylation with
dibromomethane followed by dehalodecarboxylation16 afforded
α-alkylidene γ-butryolactone 3c. This substructure is featured in
3% of all known natural products, and members of this subclass
exhibit a wide range of biological activity.17 Due to the
REFERENCES
■
(1) (a) Noyori, R.; Tokunaga, M.; Kitamura, M. Bull. Chem. Soc. Jpn.
1995, 68, 36. (b) Genet, J. P. Acc. Chem. Res. 2003, 36, 908. For
recent reviews on DKR see: (c) Pellissier, H. Tetrahedron 2008, 64,
1563. (d) Pellissier, H. Tetrahedron 2011, 67, 3769.
(2) Noyori, R.; Ikeda, T.; Ohkuma, M.; Widhalm, M.; Kitamura, H.;
Takaya, S.; Akutagawa, S.; Sayo, N.; Saito, T J. Am. Chem. Soc. 1989,
111, 9134.
a
Scheme 2. Synthetic Utility of Lactone Products
(3) Shimizu, H.; Nagasaki, I.; Matsumura, K.; Sayo, N.; Saito, T. Acc.
Chem. Res. 2007, 40, 1385.
(4) For example: (a) Patel, R. N.; Banerjee, A.; Howell, J. M.;
McNamee, D. B.; Mirfakhrae, D; Nanduri, V.; Thottathil, J. K.; Szarka,
L. J. Tetrahedron: Asymmetry 1993, 4, 2069. (b) Steward, K. M.;
Johnson, J. S. Org. Lett. 2010, 12, 2864.
(5) For examples of the Stetter reaction with glyoxamides see:
(a) Liu, Q.; Perreault, S.; Rovis, T. J. Am. Chem. Soc. 2008, 130, 14066.
(b) Liu, Q.; Rovis, T. Org. Lett. 2009, 11, 2856. (c) Vora, H. U.;
Lathrop, H. P.; Reynolds, N. T.; Kerr, M. S.; Read de Alaniz, J.; Rovis,
T. Org. Synth. 2010, 87, 350. (d) Stetter, H.; Skobel, H. Chem. Ber.
1987, 120, 643.
a
Conditions: (a) allyl bromide (2 equiv), DBU (2 equiv), THF, rt, 2 h,
94%; (b) LiCl, DMSO, 140 °C, 87%; (c) (i) K2CO3, dibromo-
methane, 84%, (ii) LiCl, DMSO, 140 °C, 87%.
(6) Hashiguchi, S.; Fujii, A.; Ikariya, T.; Noyori, R. J. Am. Chem. Soc.
1995, 117, 7562.
7331
dx.doi.org/10.1021/ja3027136 | J. Am. Chem. Soc. 2012, 134, 7329−7332